Results 1 to 10 of about 648 (69)
Cardiac tissue engineering [PDF]
Journal of the Serbian Chemical Society, 2005 We hypothesized that clinically sized (1-5 mm thick),compact cardiac constructs containing physiologically high density of viable cells (~108 cells/cm3) can be engineered in vitro by using biomimetic culture systems capable of providing oxygen transport ...
MILICA RADISIC, GORDANA VUNJAK-NOVAKOVIC
doaj +3 more sources
Electrospun Acellular Heart ECM for Cardiac Tissue Engineering [PDF]
Iranian Journal of Chemical Engineering, 2021 Electrospun nanofiber is one of the promising alternatives for use in tissue engineering and drug delivery due to its controllable characteristics. However, choosing an appropriate biomaterial for a specific tissue regeneration plays a significant role ...
Sh. mashayekhiyan +5 more
doaj +1 more source
Advances in Cardiac Tissue Engineering
Bioengineering, 2022 Tissue engineering has paved the way for the development of artificial human cardiac muscle patches (hCMPs) and cardiac tissue analogs, especially for treating Myocardial infarction (MI), often by increasing its regenerative abilities.
Takahiro Kitsuka +7 more
doaj +1 more source
Recapitulating Cardiac Structure and Function In Vitro from Simple to Complex Engineering
Micromachines, 2021 Cardiac tissue engineering aims to generate in vivo-like functional tissue for the study of cardiac development, homeostasis, and regeneration.
Ana Rita M. P. Santos +4 more
doaj +1 more source
Cardiac Organoids to Model and Heal Heart Failure and Cardiomyopathies
Biomedicines, 2021 Cardiac tissue engineering aims at creating contractile structures that can optimally reproduce the features of human cardiac tissue. These constructs are becoming valuable tools to model some of the cardiac functions, to set preclinical platforms for ...
Magali Seguret +3 more
doaj +1 more source
Artificial Scaffolds in Cardiac Tissue Engineering
Life, 2022 Cardiovascular diseases are a leading cause of death worldwide. Current treatments directed at heart repair have several disadvantages, such as a lack of donors for heart transplantation or non-bioactive inert materials for replacing damaged tissue ...
Jorge A. Roacho-Pérez +11 more
doaj +1 more source
Nanomaterials for Cardiac Tissue Engineering
Molecules, 2020 End stage heart failure is a major cause of death in the US. At present, organ transplant and left-ventricular assist devices remain the only viable treatments for these patients.
Devang R. Amin +5 more
doaj +1 more source
Whole-Heart Tissue Engineering and Cardiac Patches: Challenges and Promises
Bioengineering, 2023 Despite all the advances in preventing, diagnosing, and treating cardiovascular disorders, they still account for a significant part of mortality and morbidity worldwide.
Aram Akbarzadeh +3 more
doaj +1 more source
Nanoengineering in Cardiac Regeneration: Looking Back and Going Forward
Nanomaterials, 2020 To deliver on the promise of cardiac regeneration, an integration process between an emerging field, nanomedicine, and a more consolidated one, tissue engineering, has begun.
Caterina Cristallini +3 more
doaj +1 more source
Biomimetic Cardiac Tissue Models for In Vitro Arrhythmia Studies
Biomimetics, 2023 Cardiac arrhythmias are a major cause of cardiovascular mortality worldwide. Many arrhythmias are caused by reentry, a phenomenon where excitation waves circulate in the heart.
Aleria Aitova +7 more
doaj +1 more source